Go to content
Careers
News & Insights
Contact
Search
Strategy
Toggle submenu
The Acuitas Advantage
Our Partnerships
Our Capabilities
Science
Toggle submenu
Our LNP Technology
Our Clinical Applications
Company
Toggle submenu
About Us
Our Team
Our Community Impact
Home
News
Article
November 24, 2022
Arevalo et al. (2022) “A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes”
Science
.
DOI: 10.1126/science.abm0271